Corteva, Inc. $CTVA Shares Acquired by Savant Capital LLC

Savant Capital LLC boosted its stake in Corteva, Inc. (NYSE:CTVA) by 20.7% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 20,711 shares of the company’s stock after acquiring an additional 3,548 shares during the period. Savant Capital LLC’s holdings in Corteva were worth $1,544,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in CTVA. Gladwyn Financial Advisors Inc. purchased a new position in shares of Corteva in the 2nd quarter valued at approximately $25,000. Curat Global LLC grew its position in Corteva by 93.7% in the 2nd quarter. Curat Global LLC now owns 370 shares of the company’s stock valued at $28,000 after buying an additional 179 shares during the last quarter. Maryland Capital Advisors Inc. acquired a new position in Corteva in the 2nd quarter valued at $29,000. DHJJ Financial Advisors Ltd. raised its position in Corteva by 132.2% during the 2nd quarter. DHJJ Financial Advisors Ltd. now owns 527 shares of the company’s stock worth $39,000 after buying an additional 300 shares during the last quarter. Finally, Princeton Global Asset Management LLC lifted its stake in shares of Corteva by 61.5% in the 2nd quarter. Princeton Global Asset Management LLC now owns 525 shares of the company’s stock worth $39,000 after acquiring an additional 200 shares during the period. 81.54% of the stock is owned by hedge funds and other institutional investors.

Corteva Stock Performance

NYSE CTVA opened at $65.73 on Wednesday. The business has a 50 day moving average price of $66.07 and a 200 day moving average price of $69.56. The company has a market capitalization of $44.42 billion, a P/E ratio of 28.09, a PEG ratio of 1.49 and a beta of 0.81. Corteva, Inc. has a 1-year low of $53.40 and a 1-year high of $77.41. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.58 and a quick ratio of 1.07.

Corteva (NYSE:CTVA) last posted its earnings results on Tuesday, November 4th. The company reported ($0.23) earnings per share for the quarter, beating the consensus estimate of ($0.49) by $0.26. Corteva had a return on equity of 9.37% and a net margin of 9.19%.The company had revenue of $2.62 billion for the quarter, compared to analyst estimates of $2.47 billion. During the same quarter in the prior year, the company earned ($0.49) earnings per share. Corteva’s revenue was up 6.5% compared to the same quarter last year. Sell-side analysts expect that Corteva, Inc. will post 2.96 EPS for the current fiscal year.

Corteva Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, December 15th. Shareholders of record on Monday, December 1st will be issued a dividend of $0.18 per share. This represents a $0.72 annualized dividend and a yield of 1.1%. The ex-dividend date is Monday, December 1st. Corteva’s dividend payout ratio (DPR) is 30.77%.

Insider Transactions at Corteva

In other Corteva news, EVP Robert D. King sold 37,280 shares of the company’s stock in a transaction dated Friday, August 29th. The shares were sold at an average price of $74.20, for a total value of $2,766,176.00. Following the sale, the executive vice president owned 49,262 shares of the company’s stock, valued at $3,655,240.40. This represents a 43.08% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 0.15% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have recently issued reports on CTVA. Zacks Research lowered shares of Corteva from a “strong-buy” rating to a “hold” rating in a research note on Thursday, October 30th. Barclays upgraded Corteva from an “equal weight” rating to an “overweight” rating and boosted their target price for the stock from $75.00 to $84.00 in a research report on Wednesday, August 13th. KeyCorp reissued a “sector weight” rating on shares of Corteva in a report on Friday, October 3rd. BMO Capital Markets set a $86.00 price objective on Corteva in a report on Monday, September 15th. Finally, Royal Bank Of Canada cut their price objective on Corteva from $86.00 to $80.00 and set an “outperform” rating for the company in a research report on Friday, October 17th. Fifteen research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $79.18.

Corteva Profile

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.